Covid-19: India-made vaccine part of Pakistan jab drive

New Delhi - AstraZeneca’s Covishield vaccine to be distributed under global Covax alliance initiative.

Pakistan has secured 17 million doses of the AstraZeneca vaccine against the novel coronavirus, out of which 35-40 per cent or 6 to 6.8 million doses will be available within the first quarter of the current year, the media reported on Sunday.

The AstraZeneca vaccines are in addition to the 500,000 doses of the Sinopharm jab from China that Pakistan has already procured, The Express Tribune reported.

"Happy to share that in addition to the 500,000 doses of Sinopharm, almost 7 million does (doses) of AstraZeneca to be made available in Q1 and given to the public free of cost," Special Assistant to Prime Minister on Health Dr Faisal Sultan said in a tweet on Saturday night.

AstraZeneca’s Covishield made-in-India doses will be part of Pakistan’s free Covid vaccination drive under the , global Covax alliance, according to Dr Sultan.

“Though AstraZeneca is being prepared in India, it will come through Covax, an international alliance which has announced free vaccines for 20% of Pakistan’s population. DRAP (Drug Regulatory Authority of Pakistan) has already registered both Sinopharm and AstraZeneca,” Dr Sultan was quoted as saying in the Times of India report.